Mark D. Hicar

1.4k total citations
37 papers, 761 citations indexed

About

Mark D. Hicar is a scholar working on Immunology, Virology and Surgery. According to data from OpenAlex, Mark D. Hicar has authored 37 papers receiving a total of 761 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 13 papers in Virology and 12 papers in Surgery. Recurrent topics in Mark D. Hicar's work include HIV Research and Treatment (13 papers), Kawasaki Disease and Coronary Complications (11 papers) and Immune Cell Function and Interaction (10 papers). Mark D. Hicar is often cited by papers focused on HIV Research and Treatment (13 papers), Kawasaki Disease and Coronary Complications (11 papers) and Immune Cell Function and Interaction (10 papers). Mark D. Hicar collaborates with scholars based in United States, Netherlands and China. Mark D. Hicar's co-authors include James E. Crowe, Patricia V. Aguilar, Eric Lewin Altschuler, James Stevens, Christopher J. Keefer, Ian A. Wilson, Tshidi Tsibane, Osvaldo Martinez, Claudia Pappas and Terrence M. Tumpey and has published in prestigious journals such as Nature, PLoS ONE and Journal of Virology.

In The Last Decade

Mark D. Hicar

36 papers receiving 743 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark D. Hicar United States 13 281 224 203 195 119 37 761
David Veyer France 18 111 0.4× 356 1.6× 322 1.6× 142 0.7× 49 0.4× 53 846
Hadar Marcus Israel 20 462 1.6× 156 0.7× 141 0.7× 390 2.0× 76 0.6× 46 1.1k
Luíz Carlos de Mattos Brazil 20 240 0.9× 434 1.9× 162 0.8× 212 1.1× 43 0.4× 107 1.2k
Tiffany Chan Canada 12 286 1.0× 194 0.9× 72 0.4× 106 0.5× 159 1.3× 17 665
Amy Gillgrass Canada 19 758 2.7× 302 1.3× 142 0.7× 230 1.2× 22 0.2× 35 1.3k
Toshihide Shimada Japan 14 453 1.6× 113 0.5× 92 0.5× 103 0.5× 59 0.5× 35 733
Zoltán Bánki Austria 20 670 2.4× 148 0.7× 195 1.0× 171 0.9× 85 0.7× 48 1.0k
Lauren B. Rodda United States 9 707 2.5× 259 1.2× 181 0.9× 275 1.4× 31 0.3× 13 1.2k
You Suk Suh South Korea 12 468 1.7× 329 1.5× 111 0.5× 194 1.0× 20 0.2× 19 762
Michael Tighe United States 18 1.1k 3.8× 447 2.0× 342 1.7× 153 0.8× 35 0.3× 22 1.5k

Countries citing papers authored by Mark D. Hicar

Since Specialization
Citations

This map shows the geographic impact of Mark D. Hicar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark D. Hicar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark D. Hicar more than expected).

Fields of papers citing papers by Mark D. Hicar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark D. Hicar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark D. Hicar. The network helps show where Mark D. Hicar may publish in the future.

Co-authorship network of co-authors of Mark D. Hicar

This figure shows the co-authorship network connecting the top 25 collaborators of Mark D. Hicar. A scholar is included among the top collaborators of Mark D. Hicar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark D. Hicar. Mark D. Hicar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Andrews, Thomas S, et al.. (2025). Infections, genetics, and Alzheimer's disease: Exploring the pathogenic factors for innovative therapies. Virology. 607. 110523–110523. 3 indexed citations
2.
Hicar, Mark D., et al.. (2024). Seasonal Testing, Results, and Effect of the Pandemic on Coxsackievirus Serum Studies. Microorganisms. 12(2). 367–367. 1 indexed citations
3.
4.
5.
6.
Hicar, Mark D., et al.. (2022). Humoral cross-coronavirus responses against the S2 region in children with Kawasaki disease. Virology. 575. 83–90. 1 indexed citations
7.
Wrotniak, Brian H., Meghan Garrett, Hakimuddin T. Sojar, et al.. (2022). Antibody dependent cell cytotoxicity is maintained by the unmutated common ancestor of 6F5, a Gp41 conformational epitope targeting antibody that utilizes heavy chain VH1-2. Vaccine. 40(31). 4174–4181. 2 indexed citations
8.
Hicar, Mark D., et al.. (2022). Robust humoral immune response after boosting in children with Multisystem Inflammatory Syndrome in Children. IDCases. 29. e01569–e01569. 2 indexed citations
9.
Dayan, Peter S., et al.. (2021). Upregulation of type 1 conventional dendritic cells implicates antigen cross-presentation in multisystem inflammatory syndrome. Journal of Allergy and Clinical Immunology. 149(3). 912–922. 21 indexed citations
10.
Hicar, Mark D.. (2020). Antibodies and Immunity During Kawasaki Disease. Frontiers in Cardiovascular Medicine. 7. 94–94. 13 indexed citations
11.
Shao, Shuai, Wei‐Chiao Huang, Cuiyan Lin, et al.. (2019). An Engineered Biomimetic MPER Peptide Vaccine Induces Weakly HIV Neutralizing Antibodies in Mice. Annals of Biomedical Engineering. 48(7). 1991–2001. 17 indexed citations
12.
Martin, Meghan, et al.. (2017). Observational study of Interleukin-21 (IL-21) does not distinguish Kawasaki disease from other causes of fever in children. Pediatric Rheumatology. 15(1). 32–32. 9 indexed citations
13.
Hicar, Mark D., Xuemin Chen, Chidananda Sulli, et al.. (2016). Human Antibodies that Recognize Novel Immunodominant Quaternary Epitopes on the HIV-1 Env Protein. PLoS ONE. 11(7). e0158861–e0158861. 8 indexed citations
14.
Hicar, Mark D., Xuemin Chen, Spyros A. Kalams, et al.. (2015). Low frequency of broadly neutralizing HIV antibodies during chronic infection even in quaternary epitope targeting antibodies containing large numbers of somatic mutations. Molecular Immunology. 70. 94–103. 10 indexed citations
15.
Hicar, Mark D., Spyros A. Kalams, Paul Spearman, & James E. Crowe. (2010). Emerging studies of human HIV-specific antibody repertoires. Vaccine. 28. B18–B23. 7 indexed citations
16.
Hicar, Mark D., Xuemin Chen, Bryan Briney, et al.. (2010). Pseudovirion Particles Bearing Native HIV Envelope Trimers Facilitate a Novel Method for Generating Human Neutralizing Monoclonal Antibodies Against HIV. JAIDS Journal of Acquired Immune Deficiency Syndromes. 54(3). 223–235. 23 indexed citations
17.
Hicar, Mark D., et al.. (2010). POWASSAN VIRUS INFECTION PRESENTING AS ACUTE DISSEMINATED ENCEPHALOMYELITIS IN TENNESSEE. The Pediatric Infectious Disease Journal. 30(1). 86–88. 16 indexed citations
18.
Yu, Xiaocong, Tshidi Tsibane, Patricia McGraw, et al.. (2008). Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors. Nature. 455(7212). 532–536. 327 indexed citations
19.
Wu, Lai‐Chu, Mark D. Hicar, Joung‐Woo Hong, & Carl E. Allen. (2001). The DNA-binding ability of HIVEP3/KRC decreases upon activation of V(D)J recombination. Immunogenetics. 53(7). 564–571. 7 indexed citations
20.
Berry‐Kravis, Elizabeth, Mark D. Hicar, & Rita Ciurlionis. (1995). Reduced Cyclic AMP Production in Fragile X Syndrome: Cytogenetic and Molecular Correlations. Pediatric Research. 38(5). 638–643. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Veyer Breakdown of academic impact, for papers by Hadar Marcus Breakdown of academic impact, for papers by Luíz Carlos de Mattos Breakdown of academic impact, for papers by Tiffany Chan Breakdown of academic impact, for papers by Amy Gillgrass Breakdown of academic impact, for papers by Toshihide Shimada Breakdown of academic impact, for papers by Zoltán Bánki Breakdown of academic impact, for papers by Lauren B. Rodda Breakdown of academic impact, for papers by You Suk Suh Breakdown of academic impact, for papers by Michael Tighe
Rankless by CCL
2026